2026 AAPS National Biotechnology Conference
May 11 - 14, 2026
San Diego, California
Visit us at BOOTH #612
Join us at the 2026 AAPS National Biotechnology Conference to discuss your bioanalytical strategy, regulatory pathway, and data delivery needs, backed by proven science and scalable execution.
.png?width=320&height=157&name=NatlBiotechConfLogo_white%20(3).png "NatlBiotechConfLogo_white (3)")
BioAgilytix Presentations
RAPID FIRE
Considerations for Free Biomarker Assay Development of Multimeric Analytes
Tanya Treynor, PhD, Scientific Operations
Thursday, May 14, 2:15-2:30PM PT
Poster Presentations
TRACK 1: Applying Translational Principles Across the Development Lifecycle
Detection of Neurology Biomarkers NfL and GFAP in Human Plasma and CSF by Ultrasensitive MSD S-PLEX and Quanterix Platforms to Support Clinical Studies
Christian Braithwaite, M.S, Scientific Operations
Wednesday, May 13, 9:30-10:30AM PT
TRACK 2: Advancing Novel Medicine through Precision Science and Patient-Centric Innovation
Qualification of the MSD U-PLEX IL-33 Assay in Human Serum
Natela Dushkyan, Scientific Operations
Tuesday, May 12, 9:30-10:30AM PT
Bioanalysis Built for Modern Biologics
Integrated PK, immunogenicity, biomarker, and CMC analytical services supporting complex biologics from preclinical development through late-phase clinical studies.
Biologic drug development requires more than isolated assays. BioAgilytix delivers integrated bioanalytical strategies designed to generate reliable, phase-appropriate data while navigating regulatory complexity across global programs.
Our scientific teams develop and validate immunoassays, cell-based assays, molecular methods, and LC-MS workflows to support pharmacokinetics, immunogenicity, biomarker analysis, and CMC analytical testing. By consolidating capabilities within one global partner, sponsors reduce operational friction and accelerate program progression.
From early preclinical studies through pivotal clinical trials, BioAgilytix provides the scientific depth, global infrastructure, and regulatory expertise needed to support today’s most complex biologics.
About the event
The American Association of Pharmaceutical Scientists (AAPS) National Biotechnology Conference is a premier event that brings together scientists, researchers, and industry professionals from the biotechnology sector to explore the latest advancements and innovations in the field. This conference offers a unique platform for attendees to engage in thought-provoking discussions, attend informative sessions, and participate in workshops focused on cutting-edge biotechnological research and applications. With a diverse range of topics covering drug discovery, development, and delivery, as well as regulatory science and therapeutic innovation, the AAPS National Biotechnology Conference serves as an invaluable opportunity for professionals to network, exchange ideas, and foster collaborations that drive the future of biotechnology forward.
Schedule a meeting with our experts
© Copyright 2026 BioAgilytix Labs. All rights reserved.
